Blogs about: Asco
Featured Blog
Lung Cancer: Poster Discussion Session and Oral Abstracts, Monday June 1st
Once again, a common theme in the treatment of NSCLC was that molecular characterization is necessary and will assist in directing the appropriate therapies toward our patients. Multiple presentation… more →
MSKCC OncoNotes Conference Blogs
Really Hustle " official video "
theblogunion wrote 1 week ago: Artists :Tricky/Asco/Hypo Mashtown Director : elmino UNION(elminomediagroup) #4 Fastest Growin … more →
Updated Breast Cancer Risk Reduction Guidelines
diplomatsp wrote 1 month ago: In the United States, breast cancer is the second most common cause of death from cancer for women, … more →
Channeling Elle Woods for 4 days…
brownbeansprout wrote 1 month ago: Recently I attended an oncology conference in Orlando. I’m not an oncologist or medical doctor. I’m … more →
ZIOPHARM Presents Positive Data From Phase I Study Of Palifosfamide In Combination With Doxorubicin At ASCO
healtherm2 wrote 1 month ago: ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced that it presented final data from a Phase I study o … more →
IOPHARM Presents Positive Indibulin Translational And Dose Scheduling Data At ASCO
healtherm2 wrote 1 month ago: ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that it presented positive data from both a P … more →
ImmunoGen, Inc. Announces Encouraging Trastuzumab-DM1 Phase II Clinical Findings Presented At ASCO
healtherm2 wrote 1 month ago: ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therap … more →
Lung Cancer: Poster Discussion Session and Oral Abstracts, Monday June 1st
M. Catherine Pietanza, MD wrote 1 month ago: Once again, a common theme in the treatment of NSCLC was that molecular characterization is necessa … more →
Non-Prostate GU Oral Abstracts Session
Darren R. Feldman, MD wrote 1 month ago: GCT: Olofsson (Abst# 5015) presented on behalf of the SWENOTECA group, results of a program of inte … more →
medley soft adulto joven easy listening
— 2 comments
abc motivo wrote 1 month ago: farmacias ahumada, falabella, salcobrand, ripley, almacenes paris El domingo, en tolerancia cero, e … more →
New Drugs on the Blog -- Monday 6/1
Archie N. Tse, MD, PhD wrote 1 month ago: Beyond mTOR1 – new PI3K Kinase Pathway Inhibitors. The Clinical Science Symposium this afternoon foc … more →
Metastatic Breast Cancer Oral Session
Chau T. Dang, MD wrote 1 month ago: Robert et al reported the results of RIBBON-1 in which over 1200 patients with metastatic breast can … more →
Personalizing Melanoma Therapy
Richard D. Carvajal, MD wrote 1 month ago: Today’s Clinical Science Symposium in Melanoma highlighted several exciting abstracts that further … more →
Hereditary Cancer & Genetics
Zsofia K. Stadler, MD wrote 1 month ago: Today’s ASCO presentations in hereditary cancer and genetics continued with the theme of targeted B … more →
Upper GI, non colorectal: ORAL ABSTRACTS
Manish A. Shah, MD wrote 1 month ago: Greetings from the Upper GI Oral Session. Today, very important practice changing abstracts were pre … more →
Monday HN Sessions
Matthew G. Fury, MD, PhD wrote 1 month ago: At the Clinical Science Symposium, Abstract 6002 summarized the final results of a phase II study o … more →
GYN Monday update
Jason A. Konner, MD wrote 1 month ago: Thinning crowds today betrayed increasing ASCO-weariness as the meeting draws near its close. The f … more →
In these shoes?
— 4 comments
Kerri Wachter wrote 1 month ago: from the annual meeting of the American Society of Clinical Oncology in Orlando Image courtesy of Fl … more →
Sarcoma Clinical Science Symposium and Oral Presentation June 1, 2009
David R. D'Adamo, MD, PhD wrote 1 month ago: There were two sarcoma sessions that I will report on today, a Clinical Science Symposium and the O … more →
5-31-09 General Poster Session Non-Prostate GU
Darren R. Feldman, MD wrote 1 month ago: Among the many abstracts presented today in the general poster session, I’ll highlight a few that c … more →
Have your say. Start a blog.
See our free features →
An 
Experiment
